Vontier (VNT) Competitors $35.76 +0.12 (+0.34%) Closing price 03:59 PM EasternExtended Trading$36.03 +0.27 (+0.75%) As of 04:34 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock VNT vs. TER, RVTY, AVTR, BIO.B, NVMI, MIR, ST, CAMT, TXG, and TRNSShould you be buying Vontier stock or one of its competitors? The main competitors of Vontier include Teradyne (TER), Revvity (RVTY), Avantor (AVTR), Bio-Rad Laboratories (BIO.B), Nova (NVMI), Mirion Technologies (MIR), Sensata Technologies (ST), Camtek (CAMT), 10x Genomics (TXG), and Transcat (TRNS). These companies are all part of the "measuring and control equipment" industry. Vontier vs. Teradyne Revvity Avantor Bio-Rad Laboratories Nova Mirion Technologies Sensata Technologies Camtek 10x Genomics Transcat Vontier (NYSE:VNT) and Teradyne (NASDAQ:TER) are both business services companies, but which is the better business? We will compare the two companies based on the strength of their media sentiment, institutional ownership, valuation, risk, analyst recommendations, community ranking, profitability, dividends and earnings. Does the media favor VNT or TER? In the previous week, Teradyne had 12 more articles in the media than Vontier. MarketBeat recorded 29 mentions for Teradyne and 17 mentions for Vontier. Vontier's average media sentiment score of 1.38 beat Teradyne's score of 1.30 indicating that Vontier is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Vontier 11 Very Positive mention(s) 1 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Teradyne 21 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has preferable earnings & valuation, VNT or TER? Teradyne has lower revenue, but higher earnings than Vontier. Vontier is trading at a lower price-to-earnings ratio than Teradyne, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioVontier$2.96B1.78$422.20M$2.4614.48Teradyne$2.91B4.35$542.37M$3.5422.25 Which has more risk and volatility, VNT or TER? Vontier has a beta of 1.29, indicating that its share price is 29% more volatile than the S&P 500. Comparatively, Teradyne has a beta of 1.7, indicating that its share price is 70% more volatile than the S&P 500. Is VNT or TER a better dividend stock? Vontier pays an annual dividend of $0.10 per share and has a dividend yield of 0.3%. Teradyne pays an annual dividend of $0.48 per share and has a dividend yield of 0.6%. Vontier pays out 4.1% of its earnings in the form of a dividend. Teradyne pays out 13.6% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Teradyne has raised its dividend for 1 consecutive years. Teradyne is clearly the better dividend stock, given its higher yield and longer track record of dividend growth. Do institutionals & insiders hold more shares of VNT or TER? 95.8% of Vontier shares are owned by institutional investors. Comparatively, 99.8% of Teradyne shares are owned by institutional investors. 1.0% of Vontier shares are owned by insiders. Comparatively, 0.2% of Teradyne shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth. Does the MarketBeat Community believe in VNT or TER? Teradyne received 39 more outperform votes than Vontier when rated by MarketBeat users. However, 53.93% of users gave Vontier an outperform vote while only 48.07% of users gave Teradyne an outperform vote. CompanyUnderperformOutperformVontierOutperform Votes4853.93% Underperform Votes4146.07% TeradyneOutperform Votes8748.07% Underperform Votes9451.93% Is VNT or TER more profitable? Teradyne has a net margin of 19.23% compared to Vontier's net margin of 14.17%. Vontier's return on equity of 43.22% beat Teradyne's return on equity.Company Net Margins Return on Equity Return on Assets Vontier14.17% 43.22% 10.38% Teradyne 19.23%19.08%14.47% Do analysts rate VNT or TER? Vontier presently has a consensus price target of $44.83, suggesting a potential upside of 25.87%. Teradyne has a consensus price target of $117.56, suggesting a potential upside of 49.25%. Given Teradyne's higher possible upside, analysts clearly believe Teradyne is more favorable than Vontier.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Vontier 0 Sell rating(s) 2 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 2.71Teradyne 2 Sell rating(s) 3 Hold rating(s) 11 Buy rating(s) 1 Strong Buy rating(s) 2.65 SummaryTeradyne beats Vontier on 15 of the 22 factors compared between the two stocks. Get Vontier News Delivered to You Automatically Sign up to receive the latest news and ratings for VNT and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart VNT vs. The Competition Export to ExcelMetricVontierFluid meters & counting devices IndustryBusiness SectorNYSE ExchangeMarket Cap$5.27B$6.22B$24.44B$19.31BDividend Yield0.27%0.42%2.48%3.83%P/E Ratio12.9635.1933.9434.57Price / Sales1.785.09266.8934.96Price / Cash10.1425.4930.9317.51Price / Book5.008.395.414.69Net Income$422.20M$273.57M$196.34M$1.02B7 Day Performance-3.26%-1.83%-0.38%-1.82%1 Month Performance19.33%18.06%15.71%7.40%1 Year Performance-12.65%4.65%17.97%4.07% Vontier Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)VNTVontier4.0085 of 5 stars$35.76+0.3%$44.83+25.4%-12.0%$5.29B$2.96B13.008,100Positive NewsAnalyst ForecastTERTeradyne4.9501 of 5 stars$81.47-1.5%$117.56+44.3%-43.7%$13.07B$2.91B24.476,500Positive NewsAnalyst RevisionRVTYRevvity4.0568 of 5 stars$94.31+1.1%$125.64+33.2%-20.6%$11.12B$2.77B42.6716,700News CoveragePositive NewsAnalyst RevisionAVTRAvantor4.9093 of 5 stars$13.37-0.3%$18.88+41.2%-49.6%$9.11B$6.69B12.8614,500Positive NewsGap UpBIO.BBio-Rad LaboratoriesN/A$250.08flatN/A-10.7%$7.00B$2.54B-3.858,200NVMINova3.1059 of 5 stars$190.17-0.8%$277.00+45.7%-9.7%$5.59B$743.95M33.131,180News CoveragePositive NewsAnalyst UpgradeGap DownMIRMirion Technologies0.9933 of 5 stars$17.54+1.8%$18.75+6.9%+62.3%$4.07B$870.20M-92.322,870Positive NewsSTSensata Technologies4.9259 of 5 stars$26.70-1.7%$34.08+27.7%-39.9%$3.91B$3.84B31.7920,800Positive NewsAnalyst ForecastCAMTCamtek4.1843 of 5 stars$65.30-1.0%$90.78+39.0%-35.8%$2.98B$450.86M26.98400Analyst UpgradeTXG10x Genomics4.3936 of 5 stars$8.93-4.9%$15.81+77.0%-65.3%$1.09B$624.66M-5.881,240Analyst ForecastTRNSTranscat1.2202 of 5 stars$81.18-0.1%$111.50+37.3%-36.3%$755.71M$272.20M43.88920News CoverageEarnings ReportAnalyst UpgradeAnalyst Revision Related Companies and Tools Related Companies Teradyne Competitors Revvity Competitors Avantor Competitors Bio-Rad Laboratories Competitors Nova Competitors Mirion Technologies Competitors Sensata Technologies Competitors Camtek Competitors 10x Genomics Competitors Transcat Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:VNT) was last updated on 5/22/2025 by MarketBeat.com Staff From Our PartnersThink NVDA’s run was epic? You ain’t seen nothin’ yetAsk most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...Timothy Sykes | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredElon just did WHAT!?As you may recall, Biden and the Fed were working on a central bank digital currency, or CBDC. Had they got...Brownstone Research | SponsoredThe Collapse Has Already Started — Your 401(k) Is NextThere's a major heist happening on American wealth in real time. Except this one doesn't involve masks or v...American Hartford Gold | SponsoredElon’s 2025 Silver Crisis (What It Means for You)Elon Musk is back in the spotlight—this time for fueling a global scramble for silver. Tesla's relentless p...GoldenCrest Metals | SponsoredThe Secret Map of America, Declassified…Locked inside a Maryland man’s private safe is a map. But not just any map, mind you… This map shows a “...Banyan Hill Publishing | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredThe DOJ Just Said Your Money Isn’t YoursWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vontier Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Vontier With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.